224 related articles for article (PubMed ID: 29356992)
1. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).
Thanongsaksrikul J; Srimanote P; Tongtawe P; Glab-Ampai K; Malik AA; Supasorn O; Chiawwit P; Poovorawan Y; Chaicumpa W
Arch Virol; 2018 May; 163(5):1141-1152. PubMed ID: 29356992
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
3. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
[TBL] [Abstract][Full Text] [Related]
4. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
6. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
7. [Expression and activity determination of recombinant capsid protein VP2 gene of enterovirus type 71].
Huang X; Liu G; Hu X; Du Y; Li X; Xu Y; Chen H; Xu B
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):324-7. PubMed ID: 24969459
[TBL] [Abstract][Full Text] [Related]
8. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
[TBL] [Abstract][Full Text] [Related]
9. Protein microarray-mediated detection of antienterovirus antibodies in serum.
Zhang A; Xiu B; Zhang H; Li N
J Int Med Res; 2016 Apr; 44(2):287-96. PubMed ID: 26831405
[TBL] [Abstract][Full Text] [Related]
10. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
[TBL] [Abstract][Full Text] [Related]
11. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.
Xu L; He D; Li Z; Zheng J; Yang L; Yu M; Yu H; Chen Y; Que Y; Shih JW; Liu G; Zhang J; Zhao Q; Cheng T; Xia N
Theranostics; 2014; 4(5):498-513. PubMed ID: 24669278
[TBL] [Abstract][Full Text] [Related]
12. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice.
Li YX; Zhao H; Cao RY; Deng YQ; Han JF; Zhu SY; Ma J; Liu L; Qin ED; Qin CF
Virol J; 2014 May; 11():79. PubMed ID: 24885030
[TBL] [Abstract][Full Text] [Related]
14. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
15. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
16. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies.
Liu Q; Huang X; Ku Z; Wang T; Liu F; Cai Y; Li D; Leng Q; Huang Z
J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Characterization of Neutralizing Hen Antibodies to
Mwale PF; Lee CH; Huang PN; Tseng SN; Shih SR; Huang HY; Leu SJ; Huang YJ; Chiang LC; Mao YC; Wang WC; Yang YY
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923724
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies for diagnosis of enterovirus 71.
Xu L; Huang KJ; Ho TS; Liu CC; Lee YR; Lin CY; Shiuan D; Jiang XH
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):386-94. PubMed ID: 24328741
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein.
Lim XF; Jia Q; Chow VT; Kwang J
J Virol Methods; 2013 Mar; 188(1-2):76-82. PubMed ID: 23219932
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach.
Kirk K; Poh CL; Fecondo J; Pourianfar H; Shaw J; Grollo L
Vaccine; 2012 Nov; 30(49):7105-10. PubMed ID: 23022400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
